GI Windows news releases have been published by key medical device and financial media channels, including MD+DI, MassDevice, Business Wire, MedGadget,
Venture Capital Journal and more.
July 20, 2021 – New Study of a Novel Metabolic Procedure with Self-Assembling Magnets for Obese Patients with Type 2 Diabetes deemed safe and feasible.
January 26, 2021 – GI Windows featured in JJDC 2020 Annual Newsletter highlighting it's investment in GI Windows
December 8, 2020 – GI Windows Named Winner of Emerging MedTech Company of the Year
September 30, 2020 – U.S. FDA Grants GI Windows Medical Corp, Breakthrough Device Designation for Magnetic Anastomosis Technology
August 19, 2020 – GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1. The financing attracted Johnson & Johnson Innovation - JJDC, along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investor
December 12, 2019 – GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $14.6 million Series A financing